Pitrè D, Facino R M
Farmaco Sci. 1976 Oct;31(10):755-62.
The metabolism of iopronic acid, 2(2[(3-acetamido-2,4,6-triiodophenoxy)ethoxy]methyl)butyric acid, was studied in vitro using rat liver microsomes as enzyme source. By means of solvent extraction, T.L.C., H.P.L.C. and mass spectrometry, the hydroxyethyl (3-acetamido-2,4,6-triiodophenyl) ether and the 3-acetamido-2,4,6-triiodophenoxyacetic acid have been identified as the metabolities of the parent drug. No deiodinated metabolites were found. The probable mechanism of the in vitro formation of the metabolites is discussed.
以大鼠肝微粒体作为酶源,在体外研究了碘普罗酸(2(2[(3 - 乙酰氨基 - 2,4,6 - 三碘苯氧基)乙氧基]甲基)丁酸)的代谢情况。通过溶剂萃取、薄层层析、高效液相色谱和质谱分析,已鉴定出羟乙基(3 - 乙酰氨基 - 2,4,6 - 三碘苯基)醚和3 - 乙酰氨基 - 2,4,6 - 三碘苯氧基乙酸为母体药物的代谢产物。未发现脱碘代谢产物。讨论了体外形成这些代谢产物的可能机制。